| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |